Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.
Status:
Completed
Trial end date:
2019-09-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the optimally-tolerated regimens (OTR) for
lapatinib in combination with paclitaxel, carboplatin with and without trastuzumab in
patients with metastatic breast cancer.